This document is an excerpt from the EUR-Lex website
Document C:2005:186:FULL
Official Journal of the European Union, C 186, 29 July 2005
Official Journal of the European Union, C 186, 29 July 2005
Official Journal of the European Union, C 186, 29 July 2005
|
ISSN 1725-2423 |
||
|
Official Journal of the European Union |
C 186 |
|
|
||
|
English edition |
Information and Notices |
Volume 48 |
|
Notice No |
Contents |
page |
|
|
I Information |
|
|
|
Commission |
|
|
2005/C 186/1 |
||
|
2005/C 186/2 |
||
|
|
Corrigenda |
|
|
2005/C 186/3 |
||
|
EN |
|
I Information
Commission
|
29.7.2005 |
EN |
Official Journal of the European Union |
C 186/1 |
Euro exchange rates (1)
28 July 2005
(2005/C 186/01)
1 euro=
|
|
Currency |
Exchange rate |
|
USD |
US dollar |
1,2100 |
|
JPY |
Japanese yen |
136,00 |
|
DKK |
Danish krone |
7,4610 |
|
GBP |
Pound sterling |
0,69070 |
|
SEK |
Swedish krona |
9,4000 |
|
CHF |
Swiss franc |
1,5625 |
|
ISK |
Iceland króna |
77,82 |
|
NOK |
Norwegian krone |
7,8985 |
|
BGN |
Bulgarian lev |
1,9560 |
|
CYP |
Cyprus pound |
0,5738 |
|
CZK |
Czech koruna |
30,186 |
|
EEK |
Estonian kroon |
15,6466 |
|
HUF |
Hungarian forint |
245,08 |
|
LTL |
Lithuanian litas |
3,4528 |
|
LVL |
Latvian lats |
0,6961 |
|
MTL |
Maltese lira |
0,4293 |
|
PLN |
Polish zloty |
4,0893 |
|
RON |
Romanian leu |
3,5191 |
|
SIT |
Slovenian tolar |
239,51 |
|
SKK |
Slovak koruna |
39,100 |
|
TRY |
Turkish lira |
1,6172 |
|
AUD |
Australian dollar |
1,5976 |
|
CAD |
Canadian dollar |
1,4940 |
|
HKD |
Hong Kong dollar |
9,4091 |
|
NZD |
New Zealand dollar |
1,7762 |
|
SGD |
Singapore dollar |
2,0151 |
|
KRW |
South Korean won |
1 243,88 |
|
ZAR |
South African rand |
8,0224 |
|
CNY |
Chinese yuan renminbi |
9,8107 |
|
HRK |
Croatian kuna |
7,3028 |
|
IDR |
Indonesian rupiah |
11 893,09 |
|
MYR |
Malaysian ringgit |
4,539 |
|
PHP |
Philippine peso |
67,899 |
|
RUB |
Russian rouble |
34,6830 |
|
THB |
Thai baht |
50,600 |
Source: reference exchange rate published by the ECB.
|
29.7.2005 |
EN |
Official Journal of the European Union |
C 186/2 |
Summary of Community decisions on marketing authorizations in respect of medicinal products from 15 June 2005 to 30 June 2005
(Published pursuant to Article 12 or Article 34 of Council Regulation (EEC) No 2309/93 (1))
(2005/C 186/02)
— Modification of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
16.6.2005 |
Tracleer |
Actelion Registration Ltd, BSI Building 13th Floor, 389 Chiswick High Road, London W4 4AL, United Kingdom |
EU/1/02/220/001-005 |
20.6.2005 |
|
20.6.2005 |
Abilify |
Otsuka Pharmaceutical Europe Ltd, Commonwealth House, 2 Chalkhill Road, Hammersmith, London W6 8DW, United Kingdom |
EU/1/04/276/021-032 |
22.6.2005 |
|
24.6.2005 |
Vistide |
Pfizer Enterprises SARL, 51, Avenue Kennedy — Rond Point du Kirchberg, L-1855 Luxembourg, Grand-Duché de Luxembourg. |
EU/1/97/037/001 |
28.6.2005 |
|
28.6.2005 |
Taxotere |
Aventis Pharma S.A., 20 avenue Raymond Aron, 92165 Antony Cedex, France |
EU/1/95/002/001-002 |
30.6.2005 |
|
28.6.2005 |
Invirase |
Roche Registration Ltd., 40, Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AY, United Kingdom |
EU/1/96/026/001-002 |
30.6.2005 |
|
28.6.2005 |
Osigraft |
Howmedica International S. de R.L., Division of Stryker Corporation, Raheen Industrial Estate, Raheen, Limerick, Ireland |
EU/1/01/179/001 |
4.7.2005 |
|
28.6.2005 |
Herceptin |
Roche Registration Limited, 40 Broadwater Road, Welwyn Garden City, Hertfordshire AL7 3AY, United Kingdom |
EU/1/00/145/001 |
30.6.2005 |
|
28.6.2005 |
Remicade |
Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland |
EU/1/99/116/001-003 |
30.6.2005 |
|
28.6.2005 |
Remicade |
Centocor B.V., Einsteinweg 101, 2333 CB Leiden, Nederland |
EU/1/99/116/001-003 |
30.6.2005 |
— Withdrawal of a marketing authorization (Article 12 of Council Regulation (EEC) No 2309/93)
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
24.6.2005 |
Valdyn |
Pfizer Limited, Sandwich, Kent, CT13 9NJ, United Kingdom |
EU/1/02/244/001-024 |
28.6.2005 |
|
24.6.2005 |
Rayzon |
Pharmacia Europe EEIG, Sandwich, Kent, CT13 9NJ, United Kingdom |
EU/1/02/210/001-008 |
29.6.2005 |
— Modification of a marketing authorization (Article 34 of Council Regulation (EEC) No 2309/93): Accepted
|
Date of the decision |
Name of the medicinal product |
Holder of the marketing authorization |
Number of the entry in the Community Register |
Date of notification |
|
16.6.2005 |
Aivlosin |
ECO Animal Health Ltd, 78 Coombe Road New Malden Surrey KT3 4QS United Kingdom |
EU/2/04/044/001 |
20.6.2005 |
|
21.6.2005 |
Dexdomitor |
Orion Corporation, Orionintie 1, FIN-02200 Espoo, Suomi |
EU/2/02/033/001 |
23.6.2005 |
|
24.6.2005 |
Dexdomitor |
Orion Corporation, Orionintie 1, FIN-02200 Espoo, Suomi |
EU/2/02/033/001 |
28.6.2005 |
|
24.6.2005 |
DRAXXIN |
PFIZER Ltd, Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom |
EU/2/03/041/001-005 |
28.6.2005 |
|
24.6.2005 |
Metacam |
Boehringer Ingelheim Vetmedica GmbH, 55216 Ingelheim am Rhein, Deutschland |
EU/2/97/004/001-011 |
28.6.2005 |
|
24.6.2005 |
Porcilis Pesti |
Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland |
EU/2/99/016/001-006 |
28.6.2005 |
Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:
|
The European Medicines Agency |
|
7, Westferry Circus, Canary Wharf |
|
London E14 4HB |
|
United Kingdom |
(1) OJ L 214 of 24.8.1993, p. 1.
Corrigenda
|
29.7.2005 |
EN |
Official Journal of the European Union |
C 186/4 |
Corrigendum to the summary of Community decisions on marketing authorisations in respect of medicinal products from 10 May 2005 to 15 June 2005
(Decision taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)
( Official Journal of the European Union C 153 of 24 June 2005 )
(2005/C 186/03)
On page 6, in the table, second column:
for:
‘Regividon’,
read:
‘Rigevidon’.